http://orcid.org/0000-0003-2468-0082
Figures
Abstract
The goal of this exploratory study was to delineate health differences among transgender subpopulations (transgender women/TW, transgender men/TM, gender nonbinary/GNB adults). 2015 Behavioral Risk Factor Surveillance System data were analyzed to compare the health of three groups (TW:N = 369; TM:N = 239; GNB:N = 156). Logistic regression and adjusted odds ratios were used to determine whether health outcomes (fair/poor health, frequent physical and mental unhealthy days, chronic health conditions, and health problems/impairments) are related to group and its interaction with personal characteristics and socioeconomic position. Group was a significant predictor of fair/poor health and frequent mental unhealthy days, revealing significant health differences between the transgender groups. The odds of poor/fair health were approximately 2.5 times higher in TM and GNB adults relative to TW. The odds of frequent mental unhealthy days for TM were approximately 1.5–2 times greater than TW and GNB adults. Among those with health insurance, the odds of fair/poor health for GNB adults was more than 1.5–2 times higher that of TM and TW. Among those without health insurance, TM had over 7 times greater odds of fair/poor health than TW. This study underscores the importance of classifying and examining the health of the transgender population as unique subpopulations, as notable health differences were discovered. TM and GNB adults have significant health concerns, requiring the attention of clinical interventions aimed at promoting health and preventing illness.
Citation: Cicero EC, Reisner SL, Merwin EI, Humphreys JC, Silva SG (2020) The health status of transgender and gender nonbinary adults in the United States. PLoS ONE 15(2): e0228765. https://doi.org/10.1371/journal.pone.0228765
Editor: Jonathan Garcia, Oregon State University, UNITED STATES
Received: February 19, 2019; Accepted: January 23, 2020; Published: February 21, 2020
Copyright: © 2020 Cicero et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The data underlying the results presented in the study are available from https://www.cdc.gov/brfss/annual_data/annual_2015.html.
Funding: ECC: F31NR017115 (Duke University School of Nursing); National Institute of Nursing Research of the National Institutes of Health; https://www.ninr.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ECC: T32NR016920 (University of California, San Francisco School of Nursing); National Institute of Nursing Research of the National Institutes of Health; https://www.ninr.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ECC: 75581; Robert Wood Johnson Foundation, Future of Nursing Scholars Program; http://futureofnursingscholars.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
The term transgender, or trans, describes an array of individuals whose sex assigned at birth differs from their current gender identity, or one’s sex of being male, female, neither, or both. In contrast, cisgender is an adjective used to describe individuals with a gender identity that aligns with their sex assigned at birth [1]. Transgender individuals who were assigned male at birth and currently identify as women or female are transgender women (TW); previously referred to as “male-to-female” [1]. Those assigned female at birth and currently identify as men or male are transgender men (TM); previously referred to as “female-to-male” [1]. People who self-identify as gender nonbinary (GNB) are members of the transgender population who have a gender identity that is inconsistent with cultural and social expectations (e.g., gender nonconforming, genderqueer, or having a gender outside the traditional female-male binary) are also members of the transgender population [2]. Some, but not all, trans people pursue gender-affirming medical interventions such as cross-sex hormones and/or gender-affirming surgeries and other body modifications [3, 4]. In the United States (U.S.), the transgender population is comprised of an estimated 1.4 million TW, TM, and GNB adults, which is based on data from the Centers for Disease Control and Prevention’s (CDC) 2014 Behavioral Risk Factor Surveillance System (BRFSS), the first time a national population-based survey provided measures to identify transgender participants [5–7]. For this study, we use the term transgender to represent the heterogeneity of individuals illustrating the diversity of gender identities, expressions, and roles found within transgender and gender nonbinary communities.
The transgender population experience health disparities and social inequalities associated with personal characteristics (age, race/ethnicity, sexual orientation, and marital status) and socioeconomic position (educational attainment, employment status, income, and health insurance) [2, 8–10], factors known to impact the health of the general public [11–13]. To date, the majority of transgender health research has taken a narrow view of health by focusing on mental health [14, 15], cross-sex hormone therapy [16, 17], and absence of engagement in health-harming behaviors [18–20]. Physical health has most often been examined in relation to HIV/AIDS in transgender health research [21–23] or gender-affirming medical interventions [17, 24, 25]. Despite limitations, these studies contribute to our limited understanding of transgender health and offer as evidence that transgender subgroups have distinct health risks and outcomes. Findings also indicate that transgender adults have unfavorable risk factors [2, 10, 26], including disproportionate levels of discrimination in healthcare settings [26–28] and worse health than their cisgender peers [29, 30]; however, health-related knowledge representing the diversity of gender identities and expressions found within the transgender population is sparse, leaving many communities underrepresented and unexplored [31–33].
Contemporary, empirically-based knowledge of transgender health is scant and lacks understanding of physical health, health problems or impairments, chronic health conditions, and the impact of individual factors known to affect health outcomes in other vulnerable populations such as socioeconomic position and sexual orientation [34, 35]. Despite a growing body of health-related literature, additional research is needed to advance our understanding of health among transgender subgroups such as TW, TM, and GNB adults. Guided by the socioecological model and the intersectionality framework, this study sought to address these knowledge gaps. Suggested by the National Academy of Medicine [36] and demonstrated by previous transgender health research [27, 37], both intersectionality [38] and the socioecological model [39] serve as a critical lens to understand the health of transgender people and how their health outcomes are influenced by individual factors. Intersectionality provides a means to understand how multiple marginalized social identities intersect creating unique experiences reflecting the systems and structures of oppression and privilege [38]. The goal of the intersectionality framework is to outline that belonging to a group with social disadvantage and relegation to another will produce different lived experiences at the individual and institutional level [38]. Whereas, the socioecological framework describes the influence of multiple environmental factors and policy context that can influence an individual’s health and health behaviors [39]. It was originally constructed to inform the development of comprehensive interventions, targeting the multifactorial mechanisms impacting health behaviors at the individual level [39]. Three implicit assumptions of the framework include 1) an individual’s health and well-being are influenced by multiple factors within their social and physical environments; 2) in addition to external factors, an individual’s health status is influenced by their own personal characteristics; and 3) to promote health and well-being one must consider the dynamic relationships and interactions between an individual and their social and physical environments, versus concentrating only on their personal characteristics [39].
Together, the frameworks posit that the overarching influence of structural determinants such as local, state, and national laws and policies affect the social, community, and institutional environments where a transgender person lives, works, and studies; consequently and distinctly influencing how each transgender subgroup copes with stress, engages in health-related behaviors, and accesses resources directed at improving their health and quality of life. By applying the frameworks to this study, we anticipate there to be health differences among the three transgender groups, and personal characteristics associated with one’s minority status (e.g., sexual orientation) will be contributing factors in the health of transgender adults.
The overall goal of this exploratory study was to increase understanding of the relationships among individual factors (personal characteristics and socioeconomic position) and health status in three transgender study groups (TW, TM, GNB adults). The specific aim was to determine whether health status outcomes are related to study group (TW, TM, GNB adults) and its interaction with personal characteristics and socioeconomic position.
Methods
This exploratory study used a descriptive and observational study design to perform a secondary analysis of publicly available data from the CDC’s 2015 BRFSS. This secondary analysis compared three transgender groups (TW, TM, GNB adults), individual factors, and health status outcomes. Individual factors included personal characteristics (age, race/ethnicity, sexual orientation, and marital status) and socioeconomic position (educational attainment, employment status, annual household income, and health insurance status). Health status outcomes included measures of self-rated general health (fair/poor health), health-related quality of life (frequent physical and frequent mental unhealthy days), two or more chronic health conditions, and three or more health problems or impairments. Three additional covariates were included in the analytic models to account for the influence of state-level factors (discriminatory laws/policies and percent voting Republican) and the effects of seasonal variation during BRFSS data collection. Institutional review board exemption was obtained from the Duke University School of Nursing.
2015 behavioral risk factor surveillance system database
The BRFSS, an annual cross-sectional telephone survey conducted by the CDC and implemented in all U.S. states and participating U.S. territories, collected data on the health and health behaviors of non-institutionalized adults, aged 18 years or older, who resided in the U.S. [40]. Interviews were conducted at the state-level where data collection was a probability sample of all households with landline and cellular telephones [40]. All BRFSS interviews began with a core set of standardized questions and were followed by optional modules and state-added questions. Data collected from the optional modules or state-added items did not affect the interview schedule [40].
In 2015, an optional module assessing gender identity and sexual orientation was available for use for the second consecutive year [41]. For the gender identity portion of this module, participants were asked, “Do you consider yourself to be transgender?”, and if affirmed they were asked, “Do you consider yourself to be male-to-female, female-to-male, or gender nonconforming?” [42, p69]. Twenty-two states (Colorado, Connecticut, Delaware, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Maryland, Massachusetts, Minnesota, Missouri, Nevada, New York, Ohio, Pennsylvania, Texas, Virginia, West Virginia, and Wisconsin) adopted this module and collected data on 764 transgender adults [43].
Of important note, if the BRFSS participants asked about the term gender nonconforming, the BRFSS surveyor would explain that gender nonconforming people “do not identify only as a man or only as a woman” [42, p70], a definition that accurately describes gender nonbinary persons [44]; whereas, gender nonconforming “describes a person whose gender expression differs from a given society’s norms for males and females” [45, p5]. Given this distinction, this study will use the term gender nonbinary in lieu of gender nonconforming.
Analysis sample
Responses to the BRFSS gender identify measure were used to classify transgender participants as TW, TM, or GNB adults. These three transgender identities represent three distinct levels of study group, the factor of main interest; the analytic sample consisted of 369 TW, 239 TM, and 156 GNB adults.
Measures
Table 1 details the study variables, their descriptions and coded values; bold indicates the key study variables and health status outcomes evaluated in the analytic models. The five health status outcomes explored were fair/poor health, frequent physical unhealthy days (5 or more days within the last 30 days), frequent mental unhealthy days (5 or more days within the last 30 days), two or more chronic health conditions, and three or more health problems or impairments.
Individual factors (personal characteristics and socioeconomic position measures) were evaluated because they reflect the social and economic factors that influence health-related beliefs, behaviors, and outcomes [11, 46]. With the inclusion of individual factors, this study allowed us to examine study group differences in health status after taking into account the influence of individual factors, as well as evaluate the influence of individual factors and their interactions with study group on health status.
State-level characteristics and seasonality were included as covariate to adjust for effects of the variables on the health outcomes [47–49]. At the state level, publicly data from the Movement Advancement Project [50] were used to indicate if the state where the BRFSS participant resides had any laws or policies that harmed or deliberately targeted transgender people, and publicly available data from Federal Election Commission [51] were accessed to determine the percentage of voters who voted for the Republican candidate in the U.S. 2012 presidential election. Both variables have been associated with health-related outcomes in both transgender and cisgender populations [48, 49, 52], and were included in the models to account for the influence of from these two state-level predictors of health. Previous studies using BRFSS data showed seasonal variations in health-related quality of life such that Winter months adversely impacted physical health, and Fall months negatively influenced mental health [47]. As such, seasonality, in this study, reflects if BRFSS data collection occurred during Winter/Fall months.
Data analysis plan
Descriptive statistics were used to detail the study variables and health status outcomes for each of the three study groups. Non-directional statistical tests were performed using SAS 9.4.1® with the level of significance set at 0.05 for each test and a posteriori contrasts. The level of significance was not adjusted for multiple outcomes and tests due to the exploratory nature of this study.
For all statistical analyses, only cluster and strata BRFSS data were incorporated to account for the complex survey design; sampling weights were excluded. The decision to exclude sampling weights in our analyses emerged from the discovery of measurement error engendered by BRFSS data collection procedures that produced a discordance between BRFSS surveyor-assigned sex and self-reported gender identity [53, 54]. As a result, 74% of TW were classified as cisgender men and 66% of TM were classified as cisgender women [54]. It is not possible to determine the classification accuracy for GNB adults because they do not identify as a man or woman. The classification accuracy of the transgender BRFSS participants was essential for the sex-specific raking algorithm BRFSS used to create sampling weights [40]. Due to the misclassification of the majority of TW and TM, inaccurate and problematic sampling weights were created [54]. The application of BRFSS sampling weights has the potential to negatively impact the validity of statistical conclusions derived from these data [54].
Study groups: Individual factors and health outcomes.
Bivariate logistic regression for binary measures and one-way analysis of variance methods for continuous measures were performed to test for study group differences in personal characteristics, socioeconomic position, state-level factors, seasonality, and health outcome. Analysis of variance procedures were conducted using a General Linear Model (GLM) approach due to unequal sample sizes of the three study groups. For binary variables, a posteriori pairwise contrasts of the study groups were conducted when a significant overall study group effect was detected. For each contrast, the effect size and its 95% confidence interval (CI) were estimated to address magnitude of effect and clinical significance.
Study groups and health outcomes: Multivariable prediction models.
Multivariable logistic regression models were utilized to determine the influence of study group, individual factors, and study group and the individual factor interaction on health status outcomes, covarying for state-level factors and seasonality. A separate analysis was conducted for each health status outcome. Each comprehensive model was then reduced to a final model using an iterative backward elimination variable selection method, whereby the least significant term was omitted from model one at a time until a final model was achieved. The final model included: (a) study group; (b) significant individual factors; (c) significant study group-by individual factor interaction term; and (c) significant state-level and/or seasonality covariates. Study group and components of a significant interaction were retained regardless of statistical significance. Statistical significance was set at 0.05 for each predictor term in the comprehensive and reduced model. Adjusted odds ratios (aOR) and their 95% CI were used to estimate effect size for significant predictor terms and the mean probabilities for subgroups of a significant interaction were obtained. A posteriori pairwise contrasts of the study groups were conducted when a significant overall study group effect or within each level of the individual factor when a significant interaction was detected.
Results
Study groups: Individual factors and health outcomes
Descriptive statistics for study measures and the results of the bivariate analyses are provided for the three study groups in Tables 2 and 3. The study groups differed significantly on being a sexual minority, uninsured, and the percentage of voters who voted for the Republican candidate in the U.S. 2012 presidential election (Table 2 and S1 Table). Compared to TM, TW were nearly 1.5 times more likely to identify as a sexual minority. GNB adults had approximately 1.75 higher odds of identifying as a sexual minority relative to TW and over 2.6 higher odds than TM. Relative to TW, the odds of being uninsured were 1.85 higher in TM and approximately 1.7 times greater for GNB adults. TM were 10% more likely to be uninsured than GNB adults.
The groups differed significantly on only one health status outcome, fair/poor heath (Table 3 and S1 Table). GNB adults reported the highest percent of having fair/poor health and were over 1.5 times more likely to report fair/poor health relative to TW and nearly 1.8 more likely than TM.
Study groups and health outcomes: Multivariable models.
Each comprehensive multivariable regression model evaluating the influence of study group, individual factors, study group-by-individual factor interactions, state-level factors, and seasonality on each health outcome was reduced to a set of final models (Table 4). Table 5 provides an overview of the significant predictors for each health outcome.
Study group.
Study group was a significant predictor of fair/poor health and frequent mental unhealthy days, revealing significant health differences among the transgender groups. The contrasts of the groups (Table 6) indicated that the odds of fair/poor health were approximately 2.3 times higher in TM and over 2.5 times higher in GNB adults relative to TW. TM had nearly 1.5 times higher odds of frequent mental unhealthy days when compared to TW, and 1.7 times more likely to report frequent mental unhealthy days relative to GNB adults.
Individual factors.
For all health outcomes, employment status was a significant predictor. Not working had higher odds of fair/poor health (aOR = 4.22), frequent physical unhealthy days (aOR = 3.38), frequent mental unhealthy days (aOR = 2.29), two or more chronic health conditions (aOR = 2.39), and three or more health problems or impairments (aOR = 5.18) when compared to employed.
Age was significant predictor of frequent mental unhealthy days and two or more chronic health conditions. For each 10-year increase in age, the odds decreased by 20% for frequent mental unhealthy days and increased by 40% for two or more chronic health conditions.
Sexual orientation was a significant predictor of fair/poor health, frequent physical unhealthy days, frequent mental unhealthy days, and three or more health problems or impairments. Sexual minority had higher odds of fair/poor health (aOR = 1.69), frequent physical unhealthy days (aOR = 1.72), frequent mental unhealthy days (aOR = 1.76), and three or more health problems or impairments (aOR = 2.72) when compared to heterosexual.
Marriage status was a significant predictor of two or more chronic health conditions and three or more health problems or impairments. Being unmarried had greater odds of two or more chronic health conditions (aOR = 1.70) and three or more health problems or impairments (aOR = 2.06) relative to being married.
Educational attainment was a significant predictor of fair/poor health. Having a high school education or less increased the odds of fair/poor health (aOR = 1.43) than those with postsecondary education.
Income was a significant predictor of frequent mental unhealthy days and three or more health problems or impairments. Having a low income increased the odds of frequent mental unhealthy days (aOR = 1.62) and three or more health problems or impairments (aOR = 2.07) than those earning more than $20K.
Health insurance status was a significant predictor of fair/poor health and three or more health problems or impairments. Uninsured had lower odds of fair/poor health (aOR = 0.73) and three or more health problems or impairments (aOR = 0.38) relative to insured.
State-level characteristics and seasonality.
Discriminatory laws/policies was a significant predictor for three or more health problems or impairments; however, seasonality was not a significant predictor of any health outcome. Living in a state that had a discriminatory law or policy that targets or harms transgender people increased the odds of three or more health problems or impairments (aOR = 1.48) relative to states without such laws or policies.
Study group interactions.
One study group interaction with an individual factor predicted fair/poor health (Tables 4 and 5). Table 7 summarizes the simple effects results comparing the study groups at each level of the individual factor. Fig 1 provides a graphical representation of this interaction, and S2 Table presents the mean probability for fair/poor health for each interaction subgroup.
GNB: gender nonbinary adults; TM: transgender men; TW: transgender women.
The interaction between study group and health insurance was a significant predictor of fair/poor health (Fig 1). The probability of fair/poor health significantly differed among transgender groups when participants reported having health insurance, as well as those without health insurance. GNB adults had the highest mean probability of fair/poor health among participants with health insurance. Among those with health insurance, the odds of fair/poor health for GNB adults was more than 2 times that of TM and over 1.5 times higher than TW. Among those without health insurance, TM had the highest mean probability of fair/poor health and had over 7 times greater odds of fair/poor health than TW.
Sensitivity analysis
A sensitivity analysis comparing the age and race/ethnicity of the participants within each study group that were included to those excluded, due to missing data, from the final adjusted models revealed no significant differences.
Power calculation
Power calculations were conducted based on the assumption of a medium effect size represented the smallest clinically meaningful effect (OR of 2.5 or its inverse of 0.40; Cohen d equivalent of 0.50). The sample sizes per study group provided at least 80% power for the bivariate analytic models and a posteriori contrasts. A sample size of 480 per study group was required to achieve 80% power to test for the relationship between study group on the five health outcomes, after adjusting for the effects of other predictors in the model. Statistical power may not have been adequate for detecting all existing study group differences in the comprehensive multivariable models.
Discussion
This exploratory and hypothesis generating study examined the health status and individual factors which influence the health of TW, TM, and GNB adults. Further, we sought to highlight the importance of classifying and examining the health of the transgender population as unique subpopulations versus one homogeneous population. Although previous research has identified significant differences in health-related individual factors and health outcomes between transgender and cisgender people [55–58], this study delineated the health differences among transgender subpopulations (groups) in order to identify transgender groups at greatest risk for poor health. Moreover, by acknowledging the heterogeneity of the transgender population, we fill gaps in knowledge about the health of TM and GNB adults, two transgender groups that have been underrepresented in contemporary empirical transgender health research. In addition to this important contribution, our findings suggest that: a) among the transgender groups, there are notable differences in the health of TW, TM, and GNB adults; b) TM have poorer overall health than TW and GNB adults; and c) transgender adults who also identify as a sexual minority have increased odds of having poorer health outcomes than transgender adults who identify as heterosexual. Overall, our findings offer further evidence that both intersectionality and the socioecological model can be used to understand the influence of induvial factors on health status and the differential effects of these correlates across diverse transgender communities.
Our findings provide strong evidence that the health of transgender adults differ among transgender groups. Notably, our findings indicated that GNB adults with health insurance have greater odds of fair/poor health than TW and TM with health insurance. This finding is inconsistent with a large body of evidence linking health insurance with greater healthcare access and improved health outcomes in the general population [59–61], but it is not surprising considering that GNB adults experience higher levels of discrimination in healthcare settings, have more unmet healthcare needs, engage in more health-harming behaviors (i.e., drug/alcohol abuse, smoking, and attempted suicide), and are less likely to have an annual health exam than other transgender groups [27, 28, 62]. Additionally, research exploring the association between discrimination and physical health outcomes in the transgender population are lacking. This represents an important area for future work, especially given that stress is associated with negative, and co-occurring, physical and mental health in other vulnerable populations [63, 64]. Finally, given the disproportionate prevalence of transgender-related discrimination and poorer health experienced by GNB adults relative to TW and TM, health researchers should routinely include transgender-inclusive measures that can identify transgender subgroups and ones that measure transgender-related stigma and discrimination.
Our findings bring attention to the health concerns of TM. We found that among transgender individuals, TM adults may have significant health concerns that require the attention of clinical interventions aimed at promoting health and preventing illness. When factors known to influence health are accounted for, TM had significantly greater odds of fair/poor health when compared to TW and greater odds of frequent mental unhealthy days when compared to both TW and GNB adults. A significant concern about the health of TM in our sample is their lack of health insurance. Not only were TM the study group with the highest percentage of uninsured, TM without health insurance had over a 7-fold increase in the odds of fair/poor health than TW without health insurance. With limited health-related literature about TM, these findings not only contribute to the current knowledge base, but also highlights that health of TM is a research priority.
Study findings suggest that being transgender and a sexual minority adult increase the odds of poorer health outcomes compared to those transgender adults who self-identify as heterosexual, although there were not significant differences across transgender groups. In our sample, sexual minority adults had nearly a 2- to 3-fold increase in poorer health outcomes. This finding underscores the importance of including both sexual orientation and gender identity measures in all health-related research; transgender and gender nonbinary people can be of any sexual orientation and can be attracted to other transgender and/or gender nonbinary people, as well as cisgender individuals. Further, the intersectionality framework indicates the importance of acknowledging the influence of being a member of multiple minority groups on an individual’s lived experiences. Findings from this study elicit the health effects stemming from such lived experiences, particularly for transgender adults who are also identify as a sexual minority person. Often, researchers examining the health of lesbian, gay, bisexual, and transgender (LGBT) individuals group all LGBT people together, compare LGB- to T-identified participants, or do not use measures to identify their transgender participants [65–71].
Our results suggest that discriminatory state-level laws and policies are significant predictors for poorer health outcomes in transgender adults, but not the percentage of state residents voting Republican variable. Excluding the voting party affiliation, these findings are consistent with prior research [52, 72]. One plausible explanation for our findings regarding state-level sociopolitical predictors may stem from the gender identity measure being an optional BRFSS module. States that have incorporated this measure have recognized the importance of collecting health-related data from transgender adults and may therefore have already enacted transgender-protective laws or policies. Without transgender health data collection conducted by all U.S. states and territories, it is difficult to further investigate this inference. Additional insight can be gained if gender identity measures are routinely included in public health surveillance and population-based surveys.
Our findings indicate that significant differences in the health of TW, TM, and GNB adults may exist; although consistent patterns between groups and across outcomes were not apparent. This finding may reflect study limitations associated with BRFSS methodology and the fact that this was a secondary analysis of cross-sectional data. Besides the gender identity module, BRFSS does not include any other survey items regarding transgender health, such as gender-affirming medical interventions (e.g., hormone therapy, surgery). Such interventions have been shown to reduce adverse mental health symptomology and improve the health and well-being of transgender people [3, 73]. However, there are significant barriers to accessing gender-affirming interventions and not all transgender people desire such interventions [2]. Future studies that examine and compare the health status of transgender communities would benefit from additional survey items pertaining to aspects of health-related behaviors known to influence the health of transgender people, such as experiences of discrimination in healthcare settings or uptake of hormone therapy.
Another limitation of this secondary analysis was low statistical power to detect all transgender group differences that may have existed. Results from our final multivariable models suggest that when factors known to influence health are accounted for, GNB adults did not have significantly different health outcomes than other transgender groups, excluding the fair/poor health outcome. In contrast, GNB adults did have the highest percentage, of any study group, of having two or more chronic health conditions, having three or more health problems or impairments, and reporting 30 physically unhealthy days. These conflicting findings may be explained by the small sample sizes of the transgender groups, particularly the GNB group, which was further reduced in size in the multivariable models due to missing data. Future research exploring the health of GNB adults is warranted, and researcher might consider oversampling GNB people in surveys to achieve adequate statistical power.
BRFSS methodology may have contributed to the small GNB sample size, as well as the other transgender groups. For the BRFSS gender identity measure, participants first had to affirm being transgender before they could self-identify as GNB; not all transgender and GNB people use the term transgender when describing themselves [5]. Further, BRFSS is a telephone-based survey, which introduces a social component to gender identity disclosure with the surveyor, including perceived stigma. This may affect any transgender or GNB participant affirming their gender identity. Equally important and specific to GNB adults is BRFSS’s description for gender nonconforming as it does not align with definitions provided by three of the predominant authorities in transgender health; the World Professional Association for Transgender Health, University of California, San Francisco Center of Excellence for Transgender Health, or The Fenway Institute’s National LGBT Health Education Center [3, 44, 45]. The BRFSS gender nonconforming definition reflects a description for a non-binary identity [44]; whereas, gender nonconforming “describes a person whose gender expression differs from a given society’s norms for males and females” [45, p5]. The BRFSS survey measures for gender identity coupled with social stigma associated with transgender identities may undercount the number of self-identified transgender, particularly GNB, respondents.
In spite of the above limitations, our findings make major contributions to understanding the health status of TW, TM, and GNB adults, including components of health that have largely not been studied. Further, our study offers insights to the importance of exploring the health of transgender groups and to the vital importance of including gender identity measures by all researchers, federal, national, and state agencies conducting public health surveillance and population surveys.
Conclusion
This study, one of the first of its kind, provides a comprehensive depiction of the health status of TW, TM, and GNB adults. Research opportunities remain rich, plentiful, and needed to further identify and prioritize health-related needs and provide the foundation to develop clinical interventions aimed at reducing the burden of illness in the transgender population.
Supporting information
S1 Table. Significant bivariate model results: A posteriori contrasts for study group, individual factors, seasonality, and health status outcomes.
Bold indicates statistical significance at the 0.05 level. CI: confidence interval; GNB: gender nonbinary adults; OR: odds ratio; TM: transgender men; TW: transgender women.
https://doi.org/10.1371/journal.pone.0228765.s001
(PDF)
S2 Table. Final multivariable model results: Significant study group interaction for fair/poor health outcome.
Least squares means and SEM for estimated probabilities, adjusted for covariates in final multivariate model. GNB: gender nonbinary adults; TM: transgender men; TW: transgender women; SEM: standard error of the mean; SG: study group.
https://doi.org/10.1371/journal.pone.0228765.s002
(PDF)
References
- 1. American Psychological Association. Guidelines for psychological practice with transgender and gender nonconforming people. Am Psychol. 2015;70(9):832–64. Epub 2015/12/15. pmid:26653312
- 2.
James SE, Herman JL, Rankin S, Keisling M, Mottet L, Ana M. The Report of the 2015 U.S. Transgender Survey. Washington, DC: National Center for Transgender Equality, 2016. https://transequality.org/sites/default/files/docs/usts/USTS-Full-Report-Dec17.pdf
- 3. Coleman E, Bockting WO, Botzer M, Cohen-Kettenis P, DeCuypere G, Feldman J, et al. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgend. 2012;13(4):165–232.
- 4. Reisner SL, Radix A, Deutsch MB. Integrated and gender-affirming transgender clinical care and research. J Acquir Immune Defic Syndr. 2016;72:S235–S42. pmid:27429189
- 5.
Gender Identity in U.S. Surveillance Group. Best practices for asking questions to identify transgender and other gender minority respondents on population-based surveys. The Williams Institute. https://williamsinstitute.law.ucla.edu/wp-content/uploads/geniuss-report-sep-2014.pdf
- 6. Conron KJ, Landers SJ, Reisner SL, Sell RL. Sex and gender in the US health surveillance system: A call to action. Am J Public Health. 2014;104(6):970–6. pmid:24825193
- 7.
Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System overview: BRFSS 2014. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2015. https://www.cdc.gov/brfss/annual_data/2014/pdf/overview_2014.pdf
- 8. Meyer IH, Brown TN, Herman JL, Reisner SL, Bockting WO. Demographic characteristics and health status of transgender adults in select US regions: Behavioral Risk Factor Surveillance System, 2014. Am J Public Health. 2017;107(4):582–9. Epub 2017/02/17. pmid:28207334
- 9. Conron KJ, Scott G, Stowell GS, Landers SJ. Transgender health in Massachusetts: Results from a household probability sample of adults. Am J Public Health. 2012;102(1):118–22. pmid:22095354
- 10. Winter S, Diamond M, Green J, Karasic D, Reed T, Whittle S, et al. Transgender people: Health at the margins of society. Lancet. 2016.
- 11. Link B, Phelan J. Social conditions as fundamental causes of disease. J Health Soc Behav. 1995; (Extra Issue):80–94.
- 12.
Marmot M. Some are more equal than others. In: Marmot M, editor. Status syndrome: How social standing affects our health and longevity. New York, NY: Henry Holt and Company; 2004. p. 13–36.
- 13. Hatzenbuehler ML, Phelan JC, Link BG. Stigma as a fundamental cause of population health inequalities. Am J Public Health. 2013;103(5):813–21. pmid:23488505
- 14. Testa RJ, Jimenez CL, Rankin S. Risk and resilience during transgender identity development: The effects of awareness and engagement with other transgender people on affect. J Gay Lesbian Ment Health. 2014;18(1):31–46.
- 15. Bockting W, Miner MH, Swinburne Romine RE, Hamilton A, Coleman E. Stigma, mental health, and resilience in an online sample of the US transgender population. Am J Public Health. 2013;103(5):943–51. Epub 2013/03/16. pmid:23488522
- 16. Deutsch MB, Bhakri V, Kubicek K. Effects of cross-sex hormone treatment on transgender women and men. Obstet Gynecol. 2015;125(3):605–10. Epub 2015/03/03. pmid:25730222
- 17. White Hughto JM, Reisner SL. A systematic review of the effects of hormone therapy on psychological functioning and quality of life in transgender individuals. Transgend Health. 2016;1(1):21–31. pmid:27595141
- 18. Blosnich JR, Brown GR, Shipherd JC, Kauth M, Piegari RI, Bossarte RM. Prevalence of gender identity disorder and suicide risk among transgender veterans utilizing veterans health administration care. Am J Public Health. 2013;103(10):e27–32. Epub 2013/08/21. pmid:23947310
- 19. Klein A, Golub SA. Family rejection as a predictor of suicide attempts and substance misuse among transgender and gender nonconforming adults. LGBT Health. 2016;3(3):193–9. Epub 2016/04/06. pmid:27046450
- 20. Horvath KJ, Iantaffi A, Swinburne-Romine R, Bockting W. A comparison of mental health, substance use, and sexual risk behaviors between rural and non-rural transgender persons. J Homosex. 2014;61(8):1117–30. pmid:24380580
- 21. Brennan J, Kuhns LM, Johnson AK, Belzer M, Wilson EC, Garofalo R. Syndemic theory and HIV-related risk among young transgender women: The role of multiple, co-occurring health problems and social marginalization. Am J Public Health. 2012;102(9):1751–7. pmid:22873480
- 22. Santos GM, Wilson EC, Rapues J, Macias O, Packer T, Raymond HF. HIV treatment cascade among transgender women in a San Francisco respondent driven sampling study. Sex Transm Infect. 2014;90(5):430–3. Epub 2014/04/10. pmid:24714446
- 23. Wilson EC, Arayasirikul S, Johnson K. Access to HIV care and support services for African American transwomen living with HIV. Int J Transgend. 2013;14(4):182–95. Epub 2013/01/01. pmid:24817835
- 24. Asscheman H, T'Sjoen G, Lemaire A, Mas M, Meriggiola MC, Mueller A, et al. Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review. Int J Androl. 2014;46(7):791–5. pmid:23944849
- 25. Asscheman H, Giltay EJ, Megens JA, de Ronde WP, van Trotsenburg MA, Gooren LJ. A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. Eur J Endocrinol. 2011;164(4):635–42. Epub 2011/01/27. pmid:21266549
- 26. Cicero EC, Reisner SL, Silva SG, Merwin EI, Humphreys JC. Health care experiences of transgender adults: An integrated mixed research literature review. ANS Adv Nurs Sci. 2019. Epub 2019/03/07. pmid:30839332
- 27. Miller LR, Grollman EA. The social costs of gender nonconformity for transgender adults: Implications for discrimination and health. Sociol Forum. 2015;30(3):809–31. pmid:27708501
- 28. Cruz TM. Assessing access to care for transgender and gender nonconforming people: A consideration of diversity in combating discrimination. Soc Sci Med. 2014;110:65–73 9p. pmid:24727533
- 29. Brown GR, Jones KT. Racial health disparities in a cohort of 5,135 transgender veterans. J Racial Ethn Health Disparities. 2014;1(4):257–66.
- 30. Brown GR, Jones KT. Mental health and medical health disparities in 5135 transgender veterans receiving healthcare in the Veterans Health Administration: A case-control study. LGBT Health. 2016;3(2):122–31. Epub 2015/12/18. pmid:26674598
- 31. Feldman J, Brown GR, Deutsch MB, Hembree W, Meyer W, Meyer-Bahlburg HF, et al. Priorities for transgender medical and healthcare research. Curr Opin Endocrinol Diabetes Obes. 2016;23(2):180–7. Epub 2016/01/31. pmid:26825469
- 32. Reisner SL, Deutsch MB, Bhasin S, Bockting W, Brown GR, Feldman J, et al. Advancing methods for US transgender health research. Curr Opin Endocrinol Diabetes Obes. 2016;23(2):198–207. Epub 2016/02/05. pmid:26845331
- 33. Bockting W, Coleman E, Deutsch M, Guillamon A, Meyer I, Meyer W III, et al. Adult development and quality of life of transgender and gender nonconforming people. Curr Opin Endocrinol Diabetes Obes. 2016;23(2):188–97. pmid:26835800
- 34. Bowleg L. The problem with the phrase women and minorities: Intersectionality–An important theoretical framework for public health. Am J Public Health. 2012;102(7):1267–73 7p. pmid:22594719
- 35. MacCarthy S, Reisner SL, Nunn A, Perez-Brumer A, Operario D. The time is now: Attention increases to transgender health in the United States but scientific knowledge gaps remain. LGBT Health. 2015. pmid:26788768
- 36.
Institute of Medicine. The Health of Lesbian, Gay, Bisexual, and Transgender People: Building a Foundation for Better Understanding: National Academies Press Washington, DC; 2011.
- 37. White Hughto JM, Reisner SL, Pachankis JE. Transgender stigma and health: A critical review of stigma determinants, mechanisms, and interventions. Soc Sci Med. 2015;147:222–31. pmid:26599625
- 38. Crenshaw K. Mapping the margins: Intersectionality, identity politics, and violence against women of color. Stanford Law Rev. 1991:1241–99.
- 39. McLeroy KR, Bibeau D, Steckler A, Glanz K. An ecological perspective on health promotion programs. Health Education & Behavior. 1988;15(4):351–77. pmid:3068205
- 40.
Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System overview: BRFSS 2015. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2016. https://www.cdc.gov/brfss/annual_data/2015/pdf/overview_2015.pdf
- 41.
Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Survey: 2014 modules by state by data set & weight 2015 [updated August 19, 2015; cited 2016 February 1]. www.cdc.gov/brfss/questionnaires/modules/state2014.htm.
- 42.
Centers for Disease Control and Prevention. 2015 Behavioral Risk Factor Surveillance System questionnaire. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2014. https://www.cdc.gov/brfss/questionnaires/pdf-ques/2015-brfss-questionnaire-12-29-14.pdf
- 43.
Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System 2015 Codebook Report. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2016. https://www.cdc.gov/brfss/annual_data/annual_2015.html
- 44.
Center of Excellence for Transgender Health, Department of Family and Community Medicine, University of California San Francisco. Guidelines for the primary and gender-affirming care of transgender and gender nonbinary people; Second edition June 2016. http://transhealth.ucsf.edu/pdf/Transgender-PGACG-6-17-16.pdf.
- 45.
The National LGBT Health Education Center. Providing affirmative care for patients with non-binary gender identities. MA: The Fenway Institute; n.d. http://www.lgbthealtheducation.org/wp-content/uploads/2016/11/Providing-Affirmative-Care-for-People-with-Non-Binary-Gender-Identities.pdf.
- 46. Krieger N, Williams DR, Moss NE. Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Public Health. 1997;18(1):341–78. pmid:9143723
- 47. Jia H, Lubetkin EI. Time Trends and Seasonal Patterns of Health-Related Quality of Life among U.S. Adults. Public Health Rep. 2009;124(5):692–701. pmid:19753947
- 48. Hatzenbuehler ML, Keyes KM, Hasin DS. State-level policies and psychiatric morbidity in lesbian, gay, and bisexual populations. Am J Public Health. 2009;99(12):2275–81. pmid:19833997
- 49. White Hughto JM, Murchison GR, Clark K, Pachankis JE, Reisner SL. Geographic and individual differences in healthcare access for U.S. transgender adults: A multilevel analysis. LGBT Health. 2016. Epub 2016/09/17. pmid:27636030
- 50.
Movement Advancement Project. Mapping LGBT Equality in America. 2015. http://www.lgbtmap.org/file/Mapping%20Equality%20for%20LGBT%20Americans%20Post%20SCOTUS.pdf
- 51.
Federal Election Commission. Federal Elections 2012. Election Results for the U.S. President, the U.S. Senate and the U.S. House of Representatives. Washington, DC: Federal Election Commission.; 2013.
- 52. Hatzenbuehler ML, McLaughlin KA, Keyes KM, Hasin DS. The impact of institutional discrimination on psychiatric disorders in lesbian, gay, and bisexual populations: a prospective study. Am J Public Health. 2010;100(3):452–9. Epub 2010/01/16. pmid:20075314
- 53. Riley NC, Blosnich JR, Bear TM, Reisner SL. Vocal timbre and the classification of respondent sex in US phone-based surveys. Am J Public Health. 2017;107:1290–4. pmid:28640682
- 54.
Ethan C. Cicero, Sari L. Reisner, Elizabeth I. Merwin, Janice C. Humphreys, Silva SG. Application of Behavioral Risk Factor Surveillance System sampling weights to transgender health measurement. Nurs Res. in press. 10.xxx/yyyyy.
- 55. Streed CG Jr, McCarthy EP, Haas JS. Association between gender minority status and self-reported physical and mental health in the United States. JAMA internal medicine. 2017;177:1210–2. pmid:28558100
- 56. Crissman HP, Berger MB, Graham LF, Dalton VK. Transgender Demographics: A Household Probability Sample of US Adults, 2014. Am J Public Health. 2017;107(2):213–5. pmid:27997239
- 57. Downing JM, Przedworski JM. Health of transgender adults in the U.S., 2014–2016. Am J Prev Med. 2018;55:336–44. Epub 2018/07/23. pmid:30031640
- 58. Lagos D. Looking at population health beyond “male” and “female”: Implications of transgender identity and gender nonconformity for population health. Demography. 2018;55:2097–117. pmid:30255426
- 59. Freeman JD, Kadiyala S, Bell JF, Martin DP. The causal effect of health insurance on utilization and outcomes in adults: A systematic review of US studies. Med Care. 2008;46(10). pmid:18815523
- 60. Wilper AP, Woolhandler S, Lasser KE, McCormick D, Bor DH, Himmelstein DU. Health insurance and mortality in US adults. Am J Public Health. 2009;99(12):2289–95. pmid:19762659
- 61.
Institute of Medicine Committee on the Consequences of Uninsurance. Care Without Coverage: Too Little, Too Late. Washington (DC): National Academies Press (US) Copyright 2002 by the National Academy of Sciences. All rights reserved, 2002.
- 62. Gonzales G, Henning-Smith C. Barriers to care among transgender and gender nonconforming adults. The Milbank Quarterly. 2017;95(4):726–48. pmid:29226450
- 63. Hayward MD, Miles TP, Crimmins EM, Yang Y. The significance of socioeconomic status in explaining the racial gap in chronic health conditions. Am Sociol Rev. 2000:910–30.
- 64. Thoits PA. Stress and health: Major findings and policy implications. J Health Soc Behav. 2010;51(1 suppl):S41–S53. pmid:20943582
- 65. Fredriksen-Goldsen KI, Kim H-J, Shiu C, Goldsen J, Emlet CA. Successful aging among LGBT older adults: Physical and mental health-related quality of life by age group. The Gerontol. 2014;55(1):154–68. pmid:25213483
- 66. Caceres BA, Makarem N, Hickey KT, Hughes TL. Cardiovascular disease disparities in sexual minority adults: An examination of the Behavioral Risk Factor Surveillance System (2014–2016). Am J Health Promot. 2019;0(0):0890117118810246. pmid:30392384
- 67. Scheer JR, Pachankis JE. Psychosocial syndemic risks surrounding physical health conditions among sexual and gender minority individuals. LGBT Health. 2019;6(8):377–85. pmid:31644383
- 68. Gonzales G, Henning-Smith C. Health disparities by sexual orientation: Results and implications from the Behavioral Risk Factor Surveillance System. J Community Health. 2017:1–10.
- 69. Patterson JG, Jabson JM, Bowen DJ. Measuring sexual and gender minority populations in health surveillance. LGBT Health. 2017;4(2):82–105. pmid:28287877
- 70. Gurung S, Ventuneac A, Rendina HJ, Savarese E, Grov C, Parsons JT. Prevalence of military sexual trauma and sexual orientation discrimination among lesbian, gay, bisexual, and transgender military personnel: A descriptive study. Sex Res and Social Policy. 2018;15(1):74–82. pmid:29868145
- 71. Mereish EH, O’Cleirigh C, Bradford JB. Interrelationships between LGBT-based victimization, suicide, and substance use problems in a diverse sample of sexual and gender minorities. Psychol Health Med. 2014;19(1):1–13. pmid:23535038
- 72. Blosnich JR, Marsiglio MC, Gao S, Gordon AJ, Shipherd JC, Kauth M, et al. Mental health of transgender veterans in US states with and without discrimination and hate crime legal protection. Am J Public Health. 2016;106(3):534–40. pmid:26794162
- 73. Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, Gooren LJ, Meyer WJ III, Spack NP, et al. Endocrine treatment of transsexual persons: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2009;94(9):3132–54. pmid:19509099